Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

39941 - 39950 of 44979 results found

Nirmatrelvir-ritonivir, COVID-19, and possible adverse cutaneous reactions

Date
Tuesday, April 11, 2023 - 4:00 AM
Description
Nirmatrelvir-ritonivir (Paxlovid) recently received emergency use authorization for the treatment of coronavirus disease 2019 (COVID-19). Literature has linked numerous cutaneous adverse effects to nirmatrelvir and ritonavir, the copackaged tablets

Sars-escape network for escape prediction of SARS-COV-2

Date
Tuesday, April 11, 2023 - 4:00 AM
Description
MOTIVATION: Viruses have coevolved with their hosts for over millions of years and learned to escape the host's immune system. Although not all genetic changes in viruses are deleterious, some significant mutations lead to the escape of neutralizing